Literature DB >> 34313697

Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial.

Nienke M Halbmeijer1, Wes Onland1, Filip Cools2, Renate Swarte3, Marja van der Heide-Jalving4, Maruschka P Merkus5, Anton H van Kaam1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34313697      PMCID： PMC8317011          DOI： 10.1001/jama.2021.9380

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.

Authors:  Wes Onland; Anton H van Kaam; Anne P De Jaegere; Martin Offringa
Journal:  Pediatrics       Date:  2010-09-13       Impact factor: 7.124

2.  Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.

Authors:  Wes Onland; Filip Cools; Andre Kroon; Karin Rademaker; Maruschka P Merkus; Peter H Dijk; Henrica L van Straaten; Arjan B Te Pas; Thilo Mohns; Els Bruneel; Arno F van Heijst; Boris W Kramer; Anne Debeer; Inge Zonnenberg; Yoann Marechal; Henry Blom; Katleen Plaskie; Martin Offringa; Anton H van Kaam
Journal:  JAMA       Date:  2019-01-29       Impact factor: 56.272

Review 3.  Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.

Authors:  Lex W Doyle; Richard A Ehrenkranz; Henry L Halliday
Journal:  Neonatology       Date:  2010-02-12       Impact factor: 4.035

4.  Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.

Authors:  Olivier Baud; Clémence Trousson; Valérie Biran; Emilie Leroy; Damir Mohamed; Corinne Alberti
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272
  4 in total
  2 in total

Review 1.  Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Susanne Hay; Brett J Manley; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2021-11-11

2.  Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.

Authors:  Kristi L Watterberg; Michele C Walsh; Lei Li; Sanjay Chawla; Carl T D'Angio; Ronald N Goldberg; Susan R Hintz; Matthew M Laughon; Bradley A Yoder; Kathleen A Kennedy; Georgia E McDavid; Conra Backstrom-Lacy; Abhik Das; Margaret M Crawford; Martin Keszler; Gregory M Sokol; Brenda B Poindexter; Namasivayam Ambalavanan; Anna Maria Hibbs; William E Truog; Barbara Schmidt; Myra H Wyckoff; Amir M Khan; Meena Garg; Patricia R Chess; Anne M Reynolds; Mohannad Moallem; Edward F Bell; Lauritz R Meyer; Ravi M Patel; Krisa P Van Meurs; C Michael Cotten; Elisabeth C McGowan; Abbey C Hines; Stephanie Merhar; Myriam Peralta-Carcelen; Deanne E Wilson-Costello; Howard W Kilbride; Sara B DeMauro; Roy J Heyne; Ricardo A Mosquera; Girija Natarajan; Isabell B Purdy; Jean R Lowe; Nathalie L Maitre; Heidi M Harmon; Laurie A Hogden; Ira Adams-Chapman; Sarah Winter; William F Malcolm; Rosemary D Higgins
Journal:  N Engl J Med       Date:  2022-03-24       Impact factor: 176.079
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.